BlackRock’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
BlackRock's TSVT Position: Q2 2025 in Review
BlackRock sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 3,971,873 shares — an estimated $19.6M sold.
BlackRock first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $41.8M in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.
- BlackRock reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
- BlackRock sold 3,971,873 2seventy bio shares in Q2 2025, an estimated $19.6M.
- BlackRock first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
- BlackRock's 2seventy bio position peaked at $41.8M in Q2 2023.
- 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.
Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.